Bone marrow uptake of ferumoxytol: A preliminary study in healthy human subjects

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 6, 2014, Pages 1401-1410

  Storey, Pippa ^a   Arbini, Arnaldo A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bone marrow; ferumoxytol; iron; macrophage; MRI; USPIO

Indexed keywords

FERUMOXYTOL; CONTRAST MEDIUM; DEXTRAN; FERUMOXTRAN-10; MAGNETITE NANOPARTICLE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BONE MARROW; DIAPHYSIS; DRUG ELIMINATION; DRUG UPTAKE; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN EXPERIMENT; IMAGE ENHANCEMENT; MACROPHAGE; MALE; MIDDLE AGED; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; YOUNG ADULT; COHORT ANALYSIS; FOLLOW UP; IMAGE PROCESSING; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; PROSPECTIVE STUDY; REFERENCE VALUE;

ADULT; BONE MARROW; COHORT STUDIES; CONTRAST MEDIA; DEXTRANS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; YOUNG ADULT;

EID: 84900031525     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24320     Document Type: Article

References (38)

1. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L,. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175: 489-493.
2. Daldrup-Link HE, Rummeny EJ, Ihssen B, Kienast J, Link TM,. Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Eur Radiol 2002; 12: 1557-1566.
3. Daldrup-Link HE, Henning T, Link TM,. MR imaging of therapy-induced changes of bone marrow. Eur Radiol 2007; 17: 743-761.
4. Seneterre E, Weissleder R, Jaramillo D, et al. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology 1991; 179: 529-533.
5. Vande Berg BC, Lecouvet FE, Kanku JP, et al. Ferumoxides-enhanced quantitative magnetic resonance imaging of the normal and abnormal bone marrow: preliminary assessment. J Magn Reson Imaging 1999; 9: 322-328.
6. Metz S, Lohr S, Settles M, et al. Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas. Eur Radiol 2006; 16: 598-607.
7. Fukuda Y, Ando K, Ishikura R, et al. Superparamagnetic iron oxide (SPIO) MRI contrast agent for bone marrow imaging: differentiating bone metastasis and osteomyelitis. Magn Reson Med Sci 2006; 5: 191-196.
8. Bierry G, Jehl F, Boehm N, Robert P, Dietemann JL, Kremer S,. Macrophage imaging by USPIO-enhanced MR for the differentiation of infectious osteomyelitis and aseptic vertebral inflammation. Eur Radiol 2009; 19: 1604-1611.
9. Bierry G, Jehl F, Boehm N, et al. Macrophage activity in infected areas of an experimental vertebral osteomyelitis model: USPIO-enhanced MR imaging-feasibility study. Radiology 2008; 248: 114-123.
10. Simon GH, Raatschen HJ, Wendland MF, et al. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research. Acad Radiol 2005; 12: 1190-1197.
11. Machann J, Stefan N, Schick F,. (1)H MR spectroscopy of skeletal muscle, liver and bone marrow. Eur J Radiol 2008; 67: 275-284.
12. Chandarana H, Lim RP, Jensen JH, et al. Hepatic iron deposition in patients with liver disease: preliminary experience with breath-hold multiecho T2 -weighted sequence. AJR Am J Roentgenol 2009; 193: 1261-1267.
13. Pai AB, Nielsen JC, Kausz A, Miller P, Owen JS,. Plasma pharmacokinetics of two consecutive doses of ferumoxytol in healthy subjects. Clin Pharmacol Ther 2010; 88: 237-242.
14. Reeder SB, Cruite I, Hamilton G, Sirlin CB,. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011; 34: 729-749.
15. Hundt W, Petsch R, Helmberger T, Reiser M,. Effect of superparamagnetic iron oxide on bone marrow. Eur Radiol 2000; 10: 1495-1500.
16. Simon GH, Bauer J, Saborovski O, et al. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning. Eur Radiol 2006; 16: 738-745.
17. Muller RN, Gillis P, Moiny F, Roch A,. Transverse relaxivity of particulate MRI contrast media: from theories to experiments. Magn Reson Med 1991; 22: 178-182; discussion 195-176.
18. Bankston PW, De Bruyn PP, the permeability to carbon of the sinusoidal lining cells of the embryonic rat liver and rat bone marrow. Am J Anat 1974; 141: 281-285.
19. Hudson G, Yoffey JM,. Reticulo-endothelial cells in the bone marrow of the guinea-pig. J Anat 1963; 97: 409-416.
20. De Bruyn PP, Michelson S, Becker RP,. Endocytosis, transfer tubules, and lysosomal activity in myeloid sinusoidal endothelium. J Ultrastruct Res 1975; 53: 133-151.
21. Wickramasinghe SN,. Observations on the ultrastructure of sinusoids and reticular cells in human bone marrow. Clin Lab Haematol 1991; 13: 263-278.
22. Bianco P,. Bone and the hematopoietic niche: a tale of two stem cells. Blood 2011; 117: 5281-5288.
23. Nagasawa T, Omatsu Y, Sugiyama T,. Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells. Trends Immunol 2011; 32: 315-320.
24. Chasis JA, Mohandas N,. Erythroblastic islands: niches for erythropoiesis. Blood 2008; 112: 470-478.
25. Leimberg MJ, Prus E, Konijn AM, Fibach E,. Macrophages function as a ferritin iron source for cultured human erythroid precursors. J Cell Biochem 2008; 103: 1211-1218.
26. Crocker PR, Gordon S,. Isolation and characterization of resident stromal macrophages and hematopoietic cell clusters from mouse bone marrow. J Exp Med 1985; 162: 993-1014.
27. Kung JW, Yablon CM, Eisenberg RL,. Bone marrow signal alteration in the extremities. AJR Am J Roentgenol 2011; 196: W492-W510.
28. Laor T, Jaramillo D,. MR imaging insights into skeletal maturation: what is normal? Radiology 2009; 250: 28-38.
29. Waitches G, Zawin JK, Poznanski AK,. Sequence and rate of bone marrow conversion in the femora of children as seen on MR imaging: are accepted standards accurate? AJR Am J Roentgenol 1994; 162: 1399-1406.
30. Dwek JR, Shapiro F, Laor T, Barnewolt CE, Jaramillo D,. Normal gadolinium-enhanced MR images of the developing appendicular skeleton: Part 2. Epiphyseal and metaphyseal marrow. AJR Am J Roentgenol 1997; 169: 191-196.
31. Tavassoli M, Crosby WH,. Bone marrow histogenesis: a comparison of fatty and red marrow. Science 1970; 169: 291-293.
32. Storey P, Lim RP, Chandarana H, et al. MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults. Invest Radiol 2012; 47: 717-724.
33. Gibson S, Numa A, the importance of metabolic rate and the folly of body surface area calculations. Anaesthesia 2003; 58: 50-55.
34. Daldrup-Link HE, Mohanty A, Cuenod C, Pichler B, Link T,. New perspectives on bone marrow contrast agents and molecular imaging. Semin Musculoskelet Radiol 2009; 13: 145-156.
35. Ren J, Dimitrov I, Sherry AD, Malloy CR,. Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla. J Lipid Res 2008; 49: 2055-2062.
36. Field CJ, Angel A, Clandinin MT,. Relationship of diet to the fatty acid composition of human adipose tissue structural and stored lipids. Am J Clin Nutr 1985; 42: 1206-1220.
37. van Staveren WA, Deurenberg P, Katan MB, Burema J, de Groot LC, Hoffmans MD,. Validity of the fatty acid composition of subcutaneous fat tissue microbiopsies as an estimate of the long-term average fatty acid composition of the diet of separate individuals. Am J Epidemiol 1986; 123: 455-463.
38. Berglund J, Ahlstrom H, Kullberg J,. Model-based mapping of fat unsaturation and chain length by chemical shift imaging-phantom validation and in vivo feasibility. Magn Reson Med 2012; 68: 1815-1827.